Qube Research & Technologies (QRT)
CCRN

Qube Research & Technologies (QRT)’s Cross Country Healthcare CCRN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Sell
151,768
-420,159
-73% -$3.76M ﹤0.01% 2345
2025
Q4 		$4.63M Sell
571,927
-146,866
-20% -$1.6M ﹤0.01% 1809
2025
Q3 		$10.2M Buy
718,793
+120,546
+20% +$1.59M 0.01% 1315
2025
Q2 		$7.81M Buy
598,247
+99,132
+20% +$1.36M 0.01% 1448
2025
Q1 		$7.43M Buy
499,115
+136,970
+38% +$2.35M 0.01% 1315
2024
Q4 		$6.58M Buy
+362,145
New +$4.88M 0.01% 1342
2024
Q3 		– Sell
-19,478
Closed -$270K – 3391
2024
Q2 		$270K Buy
19,478
+6,725
+53% +$106K ﹤0.01% 2347
2024
Q1 		$239K Sell
12,753
-38,451
-75% -$769K ﹤0.01% 2936
2023
Q4 		$1.16M Sell
51,204
-64,114
-56% -$1.39M ﹤0.01% 1841
2023
Q3 		$2.86M Buy
115,318
+104,293
+946% +$2.62M 0.01% 1193
2023
Q2 		$310K Sell
11,025
-38,278
-78% -$951K ﹤0.01% 1651
2023
Q1 		$1.1M Sell
49,303
-4,831
-9% -$127K ﹤0.01% 1254
2022
Q4 		$1.44M Buy
+54,134
New +$1.77M 0.01% 1064

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CCRN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Cross Country Healthcare (CCRN) stake by 73% in Q1 2026, selling an estimated $3.76M and leaving 151,768 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

Qube Research & Technologies (QRT) first reported a position in CCRN in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.2M in Q3 2025. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Qube Research & Technologies (QRT) held 151,768 shares of Cross Country Healthcare worth $1.43M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 420,159 Cross Country Healthcare shares in Q1 2026, an estimated $3.76M.
  • Cross Country Healthcare made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2345 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cross Country Healthcare in Q4 2022 and has held it in 13 quarters since.
  • Qube Research & Technologies (QRT)'s Cross Country Healthcare position peaked at $10.2M in Q3 2025.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.